Hovius Joppe W R, Bijlsma Maarten F, van der Windt Gerritje J W, Wiersinga W Joost, Boukens Bastiaan J D, Coumou Jeroen, Oei Anneke, de Beer Regina, de Vos Alex F, van 't Veer Cornelis, van Dam Alje P, Wang Penghua, Fikrig Erol, Levi Marcel M, Roelofs Joris J T H, van der Poll Tom
Center for Experimental and Molecular Medicine (CEMM), Academic Medical Center, University of Amsterdam, AMC, Amsterdam, The Netherlands.
PLoS Pathog. 2009 May;5(5):e1000447. doi: 10.1371/journal.ppat.1000447. Epub 2009 May 22.
The causative agent of Lyme borreliosis, the spirochete Borrelia burgdorferi, has been shown to induce expression of the urokinase receptor (uPAR); however, the role of uPAR in the immune response against Borrelia has never been investigated. uPAR not only acts as a proteinase receptor, but can also, dependently or independently of ligation to uPA, directly affect leukocyte function. We here demonstrate that uPAR is upregulated on murine and human leukocytes upon exposure to B. burgdorferi both in vitro as well as in vivo. Notably, B. burgdorferi-inoculated C57BL/6 uPAR knock-out mice harbored significantly higher Borrelia numbers compared to WT controls. This was associated with impaired phagocytotic capacity of B. burgdorferi by uPAR knock-out leukocytes in vitro. B. burgdorferi numbers in vivo, and phagocytotic capacity in vitro, were unaltered in uPA, tPA (low fibrinolytic activity) and PAI-1 (high fibrinolytic activity) knock-out mice compared to WT controls. Strikingly, in uPAR knock-out mice partially backcrossed to a B. burgdorferi susceptible C3H/HeN background, higher B. burgdorferi numbers were associated with more severe carditis and increased local TLR2 and IL-1beta mRNA expression. In conclusion, in B. burgdorferi infection, uPAR is required for phagocytosis and adequate eradication of the spirochete from the heart by a mechanism that is independent of binding of uPAR to uPA or its role in the fibrinolytic system.
莱姆病的病原体——螺旋体伯氏疏螺旋体,已被证明可诱导尿激酶受体(uPAR)的表达;然而,uPAR在针对伯氏疏螺旋体的免疫反应中的作用从未被研究过。uPAR不仅作为一种蛋白酶受体,而且还能直接影响白细胞功能,这一作用可能依赖于也可能独立于与尿激酶(uPA)的结合。我们在此证明,无论是在体外还是体内,暴露于伯氏疏螺旋体后,小鼠和人类白细胞上的uPAR都会上调。值得注意的是,与野生型对照相比,接种伯氏疏螺旋体的C57BL/6 uPAR基因敲除小鼠体内的伯氏疏螺旋体数量显著更高。这与uPAR基因敲除的白细胞在体外对伯氏疏螺旋体的吞噬能力受损有关。与野生型对照相比,uPA、组织型纤溶酶原激活物(tPA,低纤溶活性)和纤溶酶原激活物抑制剂-1(PAI-1,高纤溶活性)基因敲除小鼠体内的伯氏疏螺旋体数量以及体外的吞噬能力均未改变。令人惊讶的是,在部分回交到对伯氏疏螺旋体敏感的C3H/HeN背景的uPAR基因敲除小鼠中,更高的伯氏疏螺旋体数量与更严重的心肌炎以及局部Toll样受体2(TLR2)和白细胞介素-1β(IL-1β)mRNA表达增加有关。总之,在伯氏疏螺旋体感染中,uPAR是吞噬作用以及通过一种独立于uPAR与uPA结合或其在纤溶系统中的作用的机制从心脏中充分清除螺旋体所必需的。